how does retatrutide work Retatrutide: Understanding the mechanism of action What Is Retatrutide? The Newest

Georgia Giannakopoulou, research manager, Ipsos Neurology Monitors Drug: PIPE-307 Company: Contineum Therapeutics Indication: Multiple sclerosis (remyelination) Stage: Phase II Background: PIPE307 is an oral, first-in-class, selective M1 muscarinic receptor antagonist aimed at promoting remyelination in relapsingremitting multiple sclerosis (RRMS)

2024;22(6):e8819

It regulates calcium absorption, maintains bone strength, supports immune defense, reduces inflammation, and influences mood regulation

GLP-1 Therapies, Menopause, and Longevity: Rethinking Metabolic Health in Midlife Women When women cross the threshold of midlife, metabolism seems to shift overnight

Although human studies havent caught up yet, early rat studies suggest it might support brain tissue recovery and protect nerve cells after trauma